HCRN Directory

Merkel Cell Carcinoma

HCRN-MCC20-443

A Single Arm Phase II Study with Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination with Immunotherapy for Patients with Merkel Cell Cancer (iPRRT Study)

Status

Cancer Types

Locations

Iowa, New York, University of Iowa Holden Comprehensive Cancer Center, Weill Cornell Medicine